Rilzabrutinib May Be Promising in IgG4-Related Disease



Rilzabrutinib treatment is associated with a reduction in disease activity in patients with IgG4-related disease and enables most patients to discontinue glucocorticoids without experiencing flares.
Medscape Medical News



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *